Ramdial, J. L., Chien, K. S., Lin, R., Duong, J. T., Mehta, R. S., Oran, B., Popat, U. R., Kebriaei, P., Rezvani, K., Alatrash, G., Chen, G., Nieto, Y., Maiti, A., Short, N. J., Issa, G. C., Borthakur, G., Kantarjian, H. M., Champlin, R. E., Shpall, E. J., DiNardo, C. D. (2025). A phase II open-label study of olutasidenib post-transplant maintenance therapy for patients with IDH1-mutated myeloid malignancies.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps6583